It has been demonstrated that the inhibition of Nrf2 activity enhances the sensitivity to radiation of radioresistant triple-negative breast cancer (TNBC) stem cells (CSCs) and glioblastoma stem cells [7,60]. The gene discussed is NFE2L2; the disease is glioblastoma.